GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Issuance of Debt

Daewon Pharmaceutical Co (XKRX:003220) Issuance of Debt : ₩102,421 Mil (TTM As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Daewon Pharmaceutical Co Issuance of Debt?

Daewon Pharmaceutical Co's Issuance of Debt for the three months ended in Dec. 2024 was ₩1,000 Mil.

Daewon Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₩102,421 Mil.

Daewon Pharmaceutical Co Issuance of Debt Historical Data

The historical data trend for Daewon Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewon Pharmaceutical Co Issuance of Debt Chart

Daewon Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 72,988.96 3,652.32 42,080.95 102,421.00

Daewon Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,234.39 25,311.30 44,109.71 32,000.00 1,000.00

Daewon Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩102,421 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daewon Pharmaceutical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Daewon Pharmaceutical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Daewon Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Issuance of Debt
Comparable Companies
XKRX:243070 XKRX:033270 XKRX:067080 XKRX:256840 XKRX:000520 XKRX:003000 XKRX:176750 XKRX:389470 XKRX:476060 XKRX:249420 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
229-3 Yongdap-dong, Seongdong-gu, Seoul, KOR, 133-850
Website
https://www.daewonpharm.com
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.

Daewon Pharmaceutical Co Headlines

No Headlines